Associate Chief, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute
Appears in 1 story
Presented DeLLphi-305 results at the ESMO Congress 2026 Presidential Symposium
Small cell lung cancer in its extensive stage has held median survival near a year for decades. A phase 3 trial presented Oct. 24 at the ESMO Congress in Madrid nearly doubled that, to 21.1 months.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
